To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
ORIC Pharmaceuticals goes public
South San Francisco and San Diego-based based cancer therapy company ORIC Pharmaceuticals has raised $120 million for its IPO after pricing its 7.5 million shares at $16 per share.
